BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32203214)

  • 21. Serine Synthesis Helps Hypoxic Cancer Stem Cells Regulate Redox.
    Samanta D; Semenza GL
    Cancer Res; 2016 Nov; 76(22):6458-6462. PubMed ID: 27811150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma.
    Arlt B; Zasada C; Baum K; Wuenschel J; Mastrobuoni G; Lodrini M; Astrahantseff K; Winkler A; Schulte JH; Finkler S; Forbes M; Hundsdoerfer P; Guergen D; Hoffmann J; Wolf J; Eggert A; Kempa S; Deubzer HE
    Int J Cancer; 2021 Mar; 148(5):1219-1232. PubMed ID: 33284994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance.
    Kim D; Fiske BP; Birsoy K; Freinkman E; Kami K; Possemato RL; Chudnovsky Y; Pacold ME; Chen WW; Cantor JR; Shelton LM; Gui DY; Kwon M; Ramkissoon SH; Ligon KL; Kang SW; Snuderl M; Vander Heiden MG; Sabatini DM
    Nature; 2015 Apr; 520(7547):363-7. PubMed ID: 25855294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
    Ma X; Li B; Liu J; Fu Y; Luo Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glioma cells require one-carbon metabolism to survive glutamine starvation.
    Tanaka K; Sasayama T; Nagashima H; Irino Y; Takahashi M; Izumi Y; Uno T; Satoh N; Kitta A; Kyotani K; Fujita Y; Hashiguchi M; Nakai T; Kohta M; Uozumi Y; Shinohara M; Hosoda K; Bamba T; Kohmura E
    Acta Neuropathol Commun; 2021 Jan; 9(1):16. PubMed ID: 33468252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression via ROS/Wnt/
    Zhang X; Sun M; Jiao Y; Lin B; Yang Q
    Oxid Med Cell Longev; 2022; 2022():9029544. PubMed ID: 36105480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3.
    Jing Z; Heng W; Xia L; Ning W; Yafei Q; Yao Z; Shulan Z
    Cancer Biol Ther; 2015; 16(4):541-8. PubMed ID: 25719555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serine synthesis pathway enzyme PHGDH is critical for muscle cell biomass, anabolic metabolism, and mTORC1 signaling.
    Mäntyselkä S; Kolari K; Baumert P; Ylä-Outinen L; Kuikka L; Lahtonen S; Permi P; Wackerhage H; Kalenius E; Kivelä R; Hulmi JJ
    Am J Physiol Endocrinol Metab; 2024 Jan; 326(1):E73-E91. PubMed ID: 37991454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH.
    Zheng M; Guo J; Xu J; Yang K; Tang R; Gu X; Li H; Chen L
    Food Funct; 2019 Jun; 10(6):3386-3395. PubMed ID: 31112178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional Activation of
    Hamano M; Tomonaga S; Osaki Y; Oda H; Kato H; Furuya S
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33023086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of De Novo Serine Synthesis in Müller Cells Induced Mitochondrial Dysfunction and Aggravated Oxidative Damage.
    Zhang T; Gillies MC; Madigan MC; Shen W; Du J; Grünert U; Zhou F; Yam M; Zhu L
    Mol Neurobiol; 2018 Aug; 55(8):7025-7037. PubMed ID: 29383682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of phosphoglycerate dehydrogenase in breast cancer.
    Chandrika M; Chua PJ; Muniasamy U; Huang RYJ; Thike AA; Ng CT; Tan PH; Yip GW; Bay BH
    Breast Cancer Res Treat; 2021 Apr; 186(3):655-665. PubMed ID: 33625616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression.
    Barnabas GD; Lee JS; Shami T; Harel M; Beck L; Selitrennik M; Jerby-Arnon L; Erez N; Ruppin E; Geiger T
    Cancer Res; 2021 Mar; 81(6):1443-1456. PubMed ID: 33500247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells.
    Mullarky E; Xu J; Robin AD; Huggins DJ; Jennings A; Noguchi N; Olland A; Lakshminarasimhan D; Miller M; Tomita D; Michino M; Su T; Zhang G; Stamford AW; Meinke PT; Kargman S; Cantley LC
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2503-2510. PubMed ID: 31327531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity.
    Wang Q; Liberti MV; Liu P; Deng X; Liu Y; Locasale JW; Lai L
    Cell Chem Biol; 2017 Jan; 24(1):55-65. PubMed ID: 28042046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer.
    Jeon MJ; You MH; Han JM; Sim S; Yoo HJ; Lee WK; Kim TY; Song DE; Shong YK; Kim WG; Kim WB
    Thyroid; 2020 Nov; 30(11):1625-1638. PubMed ID: 32438862
    [No Abstract]   [Full Text] [Related]  

  • 37. Phosphoglycerate dehydrogenase positively regulates the proliferation of chicken muscle cells.
    Wang H; Hu M; Ding Z; Zhou X; Yang S; Shen Z; Yan F; Zhao A
    Poult Sci; 2022 May; 101(5):101805. PubMed ID: 35344765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menin regulates the serine biosynthetic pathway in Ewing sarcoma.
    Svoboda LK; Teh SSK; Sud S; Kerk S; Zebolsky A; Treichel S; Thomas D; Halbrook CJ; Lee HJ; Kremer D; Zhang L; Klossowski S; Bankhead AR; Magnuson B; Ljungman M; Cierpicki T; Grembecka J; Lyssiotis CA; Lawlor ER
    J Pathol; 2018 Jul; 245(3):324-336. PubMed ID: 29672864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenase.
    Guo J; Gu X; Zheng M; Zhang Y; Chen L; Li H
    Bioorg Chem; 2019 Jun; 87():16-22. PubMed ID: 30852233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma.
    Ishida CT; Zhang Y; Bianchetti E; Shu C; Nguyen TTT; Kleiner G; Sanchez-Quintero MJ; Quinzii CM; Westhoff MA; Karpel-Massler G; Prabhu VV; Allen JE; Siegelin MD
    Clin Cancer Res; 2018 Nov; 24(21):5392-5406. PubMed ID: 30037819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.